GLASGOW, SCOTLAND--(Marketwired - Oct 9, 2017) - HCi Viocare ("the Company" ( OTCQB : VICA )) is delighted to welcome Dr. John Doupis, MD, PhD to its team. Dr. Doupis joins the Scientific Advisory Board assuming the role of Director of Clinical Matters and Diabetes. Dr. Doupis is a former Clinical Research Fellow of the Joslin Diabetes Center,... more
GLASGOW, SCOTLAND - HCi Viocare (OTCQB: VICA) is pleased to announce that it has shipped the world’s 1 st Smart Diabetic Walker Boot, equipped with the company’s patent pending Flexisense technology, to a global diabetes-market leading manufacturer. The Flexisense smart diabetic walker allows the user or the clinician to identify high pressure or... more
Today we have started shipping our 4 th Generation Athletic Smart insoles to the sports shoes manufacturers with whom we are in discussions. The 4th Generation Smart insole is the closest to commercial-ready product due to its significantly higher level of durability and resolution , as well as its improved communication and connectivity... more
We are a granted participant of the 10th International Conference on Advanced Technologies & Treatments for Diabetes(ATTD) , this week in Paris . The Company has been recognized for its contribution to the development of innovative solutions in the diabetes prevention and treatment fields and has won a grant for its participation at the... more
HCi Viocare is pleased to announce that it has entered into discussions with one of the major sport shoes manufacturers in the world, New Balance Athletics, Inc . HCi Viocare enters into discussions with New Balance Athletics, Inc. http://flexisense.hciviocare.com/sports-and-well-being/more
HCi Viocare has been recognized for its contribution to the development of innovative solutions in the diabetes prevention and treatment fields by being awarded a Startup Grant for the Technology Fair at the 10th International Conference on Advanced Technologies & Treatments for Diabetes(ATTD). The Conference will take place in Paris, France... more
HCi Viocare Technologies, has signed a licensing agreement with Carilex Medical Inc. a leading medical mattresses manufacturer with global presence. The two companies combined forces in setting a common goal to redefine the way in which nursing monitoring and care of bedridden patients takes place , incorporating the groundbreaking Flexisense™... more
We are proud to be short-listed for the 2016 start-up award of the IET Innovation Awards. Flexisense has, once more, been distinguished as a disruptive innovation which demonstrates a high value solution that fills up important gaps in healthcare and achieves early commercial traction. http://conferences.theiet.org/innovation/categories/start-up/... more
HCi Viocare Technologies has developed a new application for its revolutionary sensing technology Flexisense™, now for automotive tires . Flexisense™ applied to the automotive sector brings vehicle users the future of the ultimate driving experience. Flexisense™ applied to tires is able to monitor in real time tire deformation and actual traction... more
Glasgow is hosting the 44th EMBC, the world’s largest International Conference for biomedical engineering, in 2022 at the SECC. This significant development, which constitutes a deep recognition and high acceptance of the British-Scottish scientific community, has been secured by Professor Bill Sandham , HCi Viocare’s Director, Diabetes Technology... more

Pages